CFS
CRA Financial Services’s Matinas BioPharma MTNB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-10,000
| Closed | -$1.58K | – | 270 |
|
|
2024
Q2 | $1.58K | Hold |
10,000
| – | – | ﹤0.01% | 251 |
|
|
2024
Q1 | $2.71K | Hold |
10,000
| – | – | ﹤0.01% | 240 |
|
|
2023
Q4 | $2.16K | Hold |
10,000
| – | – | ﹤0.01% | 217 |
|
|
2023
Q3 | $1.3K | Hold |
10,000
| – | – | ﹤0.01% | 203 |
|
|
2023
Q2 | $3.6K | Hold |
10,000
| – | – | ﹤0.01% | 208 |
|
|
2023
Q1 | $4.7K | Hold |
10,000
| – | – | ﹤0.01% | 204 |
|
|
2022
Q4 | $5K | Hold |
10,000
| – | – | ﹤0.01% | 203 |
|
|
2022
Q3 | $6K | Hold |
10,000
| – | – | ﹤0.01% | 189 |
|
|
2022
Q2 | $8K | Hold |
10,000
| – | – | ﹤0.01% | 202 |
|
|
2022
Q1 | $8K | Hold |
10,000
| – | – | ﹤0.01% | 206 |
|
|
2021
Q4 | $10K | Hold |
10,000
| – | – | ﹤0.01% | 206 |
|
|
2021
Q3 | $13K | Hold |
10,000
| – | – | ﹤0.01% | 194 |
|
|
2021
Q2 | $8K | Hold |
10,000
| – | – | ﹤0.01% | 188 |
|
|
2021
Q1 | $11K | Hold |
10,000
| – | – | ﹤0.01% | 174 |
|
|
2020
Q4 | $14K | Hold |
10,000
| – | – | 0.01% | 158 |
|
|
2020
Q3 | $8K | Hold |
10,000
| – | – | ﹤0.01% | 144 |
|
|
2020
Q2 | $8K | Hold |
10,000
| – | – | ﹤0.01% | 140 |
|
|
2020
Q1 | $6K | Hold |
10,000
| – | – | ﹤0.01% | 127 |
|
|
2019
Q4 | $23K | Hold |
10,000
| – | – | 0.01% | 148 |
|
|
2019
Q3 | $6K | Hold |
10,000
| – | – | ﹤0.01% | 139 |
|
|
2019
Q2 | $9K | Hold |
10,000
| – | – | 0.01% | 141 |
|
|
2019
Q1 | $11K | Hold |
10,000
| – | – | 0.01% | 140 |
|
|
2018
Q4 | $6K | Buy |
+10,000
| New | +$6K | ﹤0.01% | 132 |
|